Does Dr. HIBAH ASKARI have financial conflicts of interest?

Dr. HIBAH ASKARI (MD) has received a total of $155 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $155 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. HIBAH ASKARI?

According to CMS Open Payments data, Dr. HIBAH ASKARI received funding from SUPERNUS PHARMACEUTICALS ($40), NOVO NORDISK ($25), and ULTRAGENYX PHARMACEUTICAL ($25).

Does Dr. HIBAH ASKARI receive research grants or speaking fees?

Dr. HIBAH ASKARI has received $155 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. HIBAH ASKARI

MDReal-Time Hydrated

Specialty: Nurse Practitioner, Pediatrics

Practice Location: PIKESVILLE, MD 21208

NPI Number: 1700566627

LIFETIME INDUSTRY VALUE

$155

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ASKARI is a verified Nurse Practitioner, Pediatrics practitioner based in PIKESVILLE, MD.

Between 2021 and 2025, Dr. ASKARI had an overall industry promotional and research financial footprint of $155 as recorded in the federal CMS Open Payments database.

$155 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ASKARI's primary funding source is SUPERNUS PHARMACEUTICALS, which accounts for $40 (representing 26.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SUPERNUS PHARMACEUTICALS

Rank 1

$40

26.1%

NOVO NORDISK

Rank 2

$25

16.1%

ULTRAGENYX PHARMACEUTICAL

Rank 3

$25

16%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.